LINDSEY WOODLIEF: Open Payments
NPI 1538544473 · KINGSPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 55 payments from 14 companies in 2025. Trend: 2023 $330 · 2024 $536 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $214 |
| Aimmune Therapeutics, Inc. | 9 | $155 |
| Celltrion USA Inc. | 6 | $124 |
| Janssen Biotech, Inc. | 4 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Madrigal Pharmaceuticals | 2 | $47 |
| Gilead Sciences, Inc. | 3 | $41 |
| Ardelyx, Inc. | 2 | $41 |
| Intercept Pharmaceuticals, Inc. | 2 | $27 |
| Echosens North America, Inc. | 1 | $23 |
Products named: RINVOQ, ZENPEP, VEGZELMA, TREMFYA, XIFAXAN, REZDIFFRA, IBSRELA, OCALIVA.
Industry payments across TN — which companies pay providers there.
